Donald J. Griffith
CIK 1663251 · Chief Financial Officer · last filed 2025-12-03
Donald J. Griffith is a Chief Financial Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for SONN, was dated Dec 3, 2025. Across all open-market trades the lifetime net is −$4, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
10
-$4
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Chief Financial Officer | 0 | $1.26 | $0 | $0 | 8 | 2025-12-03 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | 144,926 | — | — | -$4 | 2 | 2016-11-28 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Disp (D) | −10,375 | $0 | EDGAR |
| 2025-07-15 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2024-12-05 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +317 | $0 | EDGAR |
| 2023-02-17 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Mixed | +2,717 | -$518 | EDGAR |
| 2022-04-08 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Mixed | +10,493 | -$1.7K | EDGAR |
| 2021-05-28 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Tax (F) | −4,235 | -$6.4K | EDGAR |
| 2020-07-02 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2020-04-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +79,928 | $0 | EDGAR |
| 2016-11-28 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Sell (S) | −1 | -$4 | EDGAR |
| 2016-11-14 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Mixed | — | $0 | EDGAR |